Cellanyx Diagnostics’ Live Tumor Cell Phenotypic Risk Stratification Test Data from ‘Normal’ Tissue Samples Recognized at AdMeTech Foundation’s First Global Summit on Precision Diagnosis for Prostate Cancer with Second Place in Poster Competition.
Read the press release here.
Leave a Comment